Error: Could not add to watchlist. X

Aposense Ltd

+ Watchlist
APNSF:US
OTC US
Price not available for APNSF:US
USD
Volume
0
Previous Close
0.25
Current P/E Ratio (TTM)
-
Earnings per Share (ILS) (TTM)
-
Market Cap (USD)
-
Shares Outstanding (m)
26.527
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Aposense Limited is a clinical stage molecular imaging and drug development company. The Company has a pipeline of products based on its patented platform technology used for targeting apoptosis. Aposense Ltd targets multiple disease categories including oncology, cardiology, and neurology.
ADDRESS
5-7 Odem Street
PO Box 7119
Petach Tikva, 49170
Israel
PHONE
972-03-921-5717
  • Miri Ben-Ami
    Chief Executive Officer
  • Dov Farkash
    Co-Manager
Show More